Cronos Group Inc. (CRON) income statement
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.17−0.02 (-0.63%)
Close on Nov 18, 2026Market cap $1.17BP/E 15.8Yield –
Cronos Group Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 45.9%
- Operating margin
- -1.4%
- Net margin
- 39.1%
- Return on equity, FY2025
- -0.9%
Financial strength
- Current ratio
- 16.18
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 828.6%
Valuation
- P/E ratio
- 15.8
- Price to sales
- 6.52
- Price to book
- 1.09
- Dividend yield
- –
See a number that looks wrong?